Company News, Regulations

Warning Letter Sent To CBD Products Maker

FDA says Houston-based firm's claims are in violation of the FD&C Act.

Wellness BioSciences Rx, Houston, TX, has been sent a warning letter by the FDA following a review of its website in September 2020 and December 2020  where it sells products containing cannabidiol (CBD). The agencies also cited posts made on social media channels.   The products included an inhaler, soft gels and drops as well as WBRx Relief Balm CBD, a topical product.   According to FDA, the claims on the website and social media website establish that the firm’s CBD products are unapprov...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters